Literature DB >> 34321494

Feasibility and effectiveness of endoscopic irreversible electroporation for the upper gastrointestinal tract: an experimental animal study.

Han Jo Jeon1, Hyuk Soon Choi1, Bora Keum2, Eun Joo Bang1, Kang Won Lee1, Sang Hyun Kim1, Sun Young Yim1, Jae Min Lee1, Eun Sun Kim1, Yeon Seok Seo1, Yoon Tae Jeen1, Hong Sik Lee1, Hoon Jai Chun1, Hong Bae Kim3, Jong Hyuk Kim4.   

Abstract

Irreversible electroporation (IRE) is a local non-thermal ablative technique currently used to treat solid tumors. Here, we investigated the clinical potency and safety of IRE with an endoscope in the upper gastrointestinal tract. Pigs were electroporated with recently designed endoscopic IRE catheters in the esophagus, stomach, and duodenum. Two successive strategies were introduced to optimize the electrical energy for the digestive tract. First, each organ was electroporated and the energy upscaled to confirm the upper limit energy inducing improper tissue results, including bleeding and perforation. Excluding the unacceptable energy from the first step, consecutive electroporations were performed with stepwise reductions in energy to identify the energy that damaged each layer. Inceptive research into inappropriate electrical intensity contributed to extensive hemorrhage and bowel perforation for each tissue above a certain energy threshold. However, experiments performed below the precluded energy accompanying hematoxylin and eosin staining and terminal deoxynucleotidyl transferase dUTP nick-end labeling assays showed that damaged mucosal area and depth significantly decreased with decreased energy. Relevant histopathology showed infiltration of inflammatory cells with pyknotic nuclei at the electroporated lesion. This investigation demonstrated the possibility of endoscopic IRE in mucosal dysplasia or early malignant tumors of the hollow viscus.
© 2021. The Author(s).

Entities:  

Year:  2021        PMID: 34321494     DOI: 10.1038/s41598-021-94583-w

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  35 in total

Review 1.  Principles of and advances in percutaneous ablation.

Authors:  Muneeb Ahmed; Christopher L Brace; Fred T Lee; S Nahum Goldberg
Journal:  Radiology       Date:  2011-02       Impact factor: 11.105

2.  Irreversible electroporation therapy in the management of locally advanced pancreatic adenocarcinoma.

Authors:  Robert C G Martin; Kelli McFarland; Susan Ellis; Vic Velanovich
Journal:  J Am Coll Surg       Date:  2012-06-21       Impact factor: 6.113

3.  Tissue ablation with irreversible electroporation.

Authors:  R V Davalos; I L M Mir; B Rubinsky
Journal:  Ann Biomed Eng       Date:  2005-02       Impact factor: 3.934

Review 4.  Preoperative chemo(radio)therapy versus primary surgery for gastroesophageal adenocarcinoma: systematic review with meta-analysis combining individual patient and aggregate data.

Authors:  Ulrich Ronellenfitsch; Matthias Schwarzbach; Ralf Hofheinz; Peter Kienle; Meinhard Kieser; Tracy E Slanger; Bryan Burmeister; David Kelsen; Donna Niedzwiecki; Christoph Schuhmacher; Susan Urba; Cornelis van de Velde; Thomas N Walsh; Marc Ychou; Katrin Jensen
Journal:  Eur J Cancer       Date:  2013-06-22       Impact factor: 9.162

Review 5.  Epidemiology of gastric cancer in Japan.

Authors:  M Inoue; S Tsugane
Journal:  Postgrad Med J       Date:  2005-07       Impact factor: 2.401

Review 6.  Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018.

Authors:  Anne F Peery; Seth D Crockett; Caitlin C Murphy; Jennifer L Lund; Evan S Dellon; J Lucas Williams; Elizabeth T Jensen; Nicholas J Shaheen; Alfred S Barritt; Sarah R Lieber; Bharati Kochar; Edward L Barnes; Y Claire Fan; Virginia Pate; Joseph Galanko; Todd H Baron; Robert S Sandler
Journal:  Gastroenterology       Date:  2018-10-10       Impact factor: 22.682

Review 7.  Electroporation: a general phenomenon for manipulating cells and tissues.

Authors:  J C Weaver
Journal:  J Cell Biochem       Date:  1993-04       Impact factor: 4.429

8.  Endoscopic stenting versus operative gastrojejunostomy for malignant gastric outlet obstruction-a systematic review and meta-analysis of randomized and non-randomized trials.

Authors:  Vinayak Nagaraja; Guy D Eslick; Michael R Cox
Journal:  J Gastrointest Oncol       Date:  2014-04

9.  Randomized phase III trial of gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer, the short-term safety and surgical results: Japan Clinical Oncology Group Study (JCOG0501).

Authors:  Masanori Terashima; Yoshiaki Iwasaki; Junki Mizusawa; Hiroshi Katayama; Kenichi Nakamura; Hitoshi Katai; Takaki Yoshikawa; Yuichi Ito; Masahide Kaji; Yutaka Kimura; Motohiro Hirao; Makoto Yamada; Akira Kurita; Masakazu Takagi; Narikazu Boku; Takeshi Sano; Mitsuru Sasako
Journal:  Gastric Cancer       Date:  2019-03-02       Impact factor: 7.701

Review 10.  New and Established Technology in Focal Ablation of the Prostate: A Systematic Review.

Authors:  Massimo Valerio; Yannick Cerantola; Scott E Eggener; Herbert Lepor; Thomas J Polascik; Arnauld Villers; Mark Emberton
Journal:  Eur Urol       Date:  2016-08-29       Impact factor: 20.096

View more
  2 in total

1.  Safety and feasibility of irreversible electroporation for the pancreatic head in a porcine model.

Authors:  Li Yan; Bin Liang; Jian Feng; Hang-Yu Zhang; Hao-Sheng Chang; Bing Liu; Yong-Liang Chen
Journal:  World J Gastrointest Oncol       Date:  2022-08-15

Review 2.  Irreversible Electroporation: An Emerging Immunomodulatory Therapy on Solid Tumors.

Authors:  Nana Zhang; Zhuoqun Li; Xuan Han; Ziyu Zhu; Zhujun Li; Yan Zhao; Zhijun Liu; Yi Lv
Journal:  Front Immunol       Date:  2022-01-07       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.